Author: International Society of Blood Transfusion. Congress
Publisher:
ISBN:
Category :
Languages : en
Pages : 922
Book Description
Proceedings of the Twelfth Congress of the International Society of Blood Transfusion: Organization and technical problems of transfusion
Author: International Society of Blood Transfusion. Congress
Publisher:
ISBN:
Category :
Languages : en
Pages : 922
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages : 922
Book Description
Monographic Series
Author: Library of Congress
Publisher:
ISBN:
Category : Monographic series
Languages : en
Pages : 912
Book Description
Publisher:
ISBN:
Category : Monographic series
Languages : en
Pages : 912
Book Description
Current Catalog
Author: National Library of Medicine (U.S.)
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 824
Book Description
First multi-year cumulation covers six years: 1965-70.
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 824
Book Description
First multi-year cumulation covers six years: 1965-70.
National Union Catalog
Author:
Publisher:
ISBN:
Category : Union catalogs
Languages : en
Pages : 616
Book Description
Publisher:
ISBN:
Category : Union catalogs
Languages : en
Pages : 616
Book Description
National Library of Medicine Current Catalog
Author: National Library of Medicine (U.S.)
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 1032
Book Description
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 1032
Book Description
Bloody Bioethics
Author: James Stacey Taylor
Publisher: Routledge
ISBN: 1000553868
Category : Philosophy
Languages : en
Pages : 170
Book Description
This is the first book to argue in favor of paying people for their blood plasma. It does not merely argue that offering compensation to plasma donors is morally permissible. It argues that prohibiting donor compensation is morally wrong—and that it is morally wrong for all of the reasons that are offered against allowing donor compensation. Opponents of donor compensation claim that it will reduce the amount and quality of plasma obtained, exploit and coerce donors, and undermine social cohesion. James Stacey Taylor argues that empirical evidence demonstrates that compensating plasma donors greatly increases the amount of plasma obtained with no adverse effects on the quality of the pharmaceutical products that are manufactured from it. Prohibiting compensation thus harms patients by reducing their access to the medicines they need. He also argues that it is the prohibition of compensation—not its offer—that exploits donors, fails to respect the moral need to secure a person’s authoritative consent to her treatment, and prevents donors from giving their informed consent to donate. Prohibiting compensation thus not only harms patients but also wrongs donors. Bloody Bioethics will appeal to researchers, advanced students, and medical professionals interested in bioethics, moral philosophy, and the moral limits of markets.
Publisher: Routledge
ISBN: 1000553868
Category : Philosophy
Languages : en
Pages : 170
Book Description
This is the first book to argue in favor of paying people for their blood plasma. It does not merely argue that offering compensation to plasma donors is morally permissible. It argues that prohibiting donor compensation is morally wrong—and that it is morally wrong for all of the reasons that are offered against allowing donor compensation. Opponents of donor compensation claim that it will reduce the amount and quality of plasma obtained, exploit and coerce donors, and undermine social cohesion. James Stacey Taylor argues that empirical evidence demonstrates that compensating plasma donors greatly increases the amount of plasma obtained with no adverse effects on the quality of the pharmaceutical products that are manufactured from it. Prohibiting compensation thus harms patients by reducing their access to the medicines they need. He also argues that it is the prohibition of compensation—not its offer—that exploits donors, fails to respect the moral need to secure a person’s authoritative consent to her treatment, and prevents donors from giving their informed consent to donate. Prohibiting compensation thus not only harms patients but also wrongs donors. Bloody Bioethics will appeal to researchers, advanced students, and medical professionals interested in bioethics, moral philosophy, and the moral limits of markets.
Technical Manual
Author: Caludia S. Cohn
Publisher:
ISBN: 9781563953705
Category : Blood
Languages : en
Pages : 816
Book Description
Publisher:
ISBN: 9781563953705
Category : Blood
Languages : en
Pages : 816
Book Description
Bibliographie générale sur les monts Nilgiri de l'Inde du sud 1603-1996
Author: Paul Hockings
Publisher: Presses Univ de Bordeaux
ISBN: 9782906621275
Category : Nilgiri Hills (India)
Languages : en
Pages : 364
Book Description
Publisher: Presses Univ de Bordeaux
ISBN: 9782906621275
Category : Nilgiri Hills (India)
Languages : en
Pages : 364
Book Description
Index of NLM Serial Titles
Author: National Library of Medicine (U.S.)
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 1516
Book Description
A keyword listing of serial titles currently received by the National Library of Medicine.
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 1516
Book Description
A keyword listing of serial titles currently received by the National Library of Medicine.
HIV and the Blood Supply
Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309053293
Category : Medical
Languages : en
Pages : 349
Book Description
During the early years of the AIDS epidemic, thousands of Americans became infected with HIV through the nation's blood supply. Because little reliable information existed at the time AIDS first began showing up in hemophiliacs and in others who had received transfusions, experts disagreed about whether blood and blood products could transmit the disease. During this period of great uncertainty, decision-making regarding the blood supply became increasingly difficult and fraught with risk. This volume provides a balanced inquiry into the blood safety controversy, which involves private sexual practices, personal tragedy for the victims of HIV/AIDS, and public confidence in America's blood services system. The book focuses on critical decisions as information about the danger to the blood supply emerged. The committee draws conclusions about what was doneâ€"and recommends what should be done to produce better outcomes in the face of future threats to blood safety. The committee frames its analysis around four critical area: Product treatmentâ€"Could effective methods for inactivating HIV in blood have been introduced sooner? Donor screening and referralâ€"including a review of screening to exlude high-risk individuals. Regulations and recall of contaminated bloodâ€"analyzing decisions by federal agencies and the private sector. Risk communicationâ€"examining whether infections could have been averted by better communication of the risks.
Publisher: National Academies Press
ISBN: 0309053293
Category : Medical
Languages : en
Pages : 349
Book Description
During the early years of the AIDS epidemic, thousands of Americans became infected with HIV through the nation's blood supply. Because little reliable information existed at the time AIDS first began showing up in hemophiliacs and in others who had received transfusions, experts disagreed about whether blood and blood products could transmit the disease. During this period of great uncertainty, decision-making regarding the blood supply became increasingly difficult and fraught with risk. This volume provides a balanced inquiry into the blood safety controversy, which involves private sexual practices, personal tragedy for the victims of HIV/AIDS, and public confidence in America's blood services system. The book focuses on critical decisions as information about the danger to the blood supply emerged. The committee draws conclusions about what was doneâ€"and recommends what should be done to produce better outcomes in the face of future threats to blood safety. The committee frames its analysis around four critical area: Product treatmentâ€"Could effective methods for inactivating HIV in blood have been introduced sooner? Donor screening and referralâ€"including a review of screening to exlude high-risk individuals. Regulations and recall of contaminated bloodâ€"analyzing decisions by federal agencies and the private sector. Risk communicationâ€"examining whether infections could have been averted by better communication of the risks.